A detailed history of Cheviot Value Management, LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Cheviot Value Management, LLC holds 579 shares of LLY stock, worth $508,072. This represents 0.11% of its overall portfolio holdings.

Number of Shares
579
Previous 574 0.87%
Holding current value
$508,072
Previous $446,000 17.49%
% of portfolio
0.11%
Previous 0.11%

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

BUY
$724.87 - $909.04 $3,624 - $4,545
5 Added 0.87%
579 $524,000
Q1 2024

May 14, 2024

SELL
$592.2 - $792.28 $266,490 - $356,526
-450 Reduced 43.95%
574 $446,000
Q2 2021

Aug 16, 2021

BUY
$180.55 - $233.54 $184,883 - $239,144
1,024 New
1,024 $235,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $834B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Cheviot Value Management, LLC Portfolio

Follow Cheviot Value Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Cheviot Value Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Cheviot Value Management, LLC with notifications on news.